Assignee
SEPRACOR INC
US·320 granted patents·75 pending applications·8,073 citations·filing 1985–2010
Top patents by PatentIndex Score
395 records- 0198US7423179B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2006·Granted Sep 9, 2008·12 cites·6 claims
- 0298US6627646B2Norastemizole polymorphsSEPRACOR INC·Filed 2001·Granted Sep 30, 2003·276 cites·13 claims
- 0398US6342496B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 29, 2002·217 cites·19 claims
- 0497US6472563B1Formoterol tartrate process and polymorphSEPRACOR INC·Filed 2001·Granted Oct 29, 2002·78 cites·14 claims
- 0596US7790772B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2009·Granted Sep 7, 2010·15 cites·6 claims
- 0696US7381724B2Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing sameSEPRACOR INC·Filed 2006·Granted Jun 3, 2008·35 cites·5 claims
- 0796US7294637B2Method of treating addiction or dependence using a ligand for a monamine receptor or transporterSEPRACOR INC·Filed 2004·Granted Nov 13, 2007·89 cites·35 claims
- 0896US7189715B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2003·Granted Mar 13, 2007·40 cites·16 claims
- 0996US7125874B2Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing sameSEPRACOR INC·Filed 2004·Granted Oct 24, 2006·43 cites·7 claims
- 1096US7087785B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2003·Granted Aug 8, 2006·28 cites·56 claims
- 1196US6762177B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2002·Granted Jul 13, 2004·41 cites·48 claims
- 1296US6458374B1Methods and compositions for treating chronic disorders using optically pure (+)-bupropionSEPRACOR INC·Filed 1999·Granted Oct 1, 2002·118 cites·17 claims
- 1396US6444673B1Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing itSEPRACOR INC·Filed 2000·Granted Sep 3, 2002·71 cites·8 claims
- 1496US6268533B1Formoterol processSEPRACOR INC·Filed 2000·Granted Jul 31, 2001·170 cites·20 claims
- 1596US5077217AMethod for membrane reactor resolution of stereoisomersSEPRACOR INC·Filed 1988·Granted Dec 31, 1991·58 cites·151 claims
- 1696US4800162AMethod for resolution of steroisomers in multiphase and extractive membrane reactorsSEPRACOR INC·Filed 1987·Granted Jan 24, 1989·78 cites·157 claims
- 1795US6645980B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Nov 11, 2003·46 cites·21 claims
- 1895US6369079B1Methods for treating irritable bowel syndrome using optically pure (+) norcisaprideSEPRACOR INC·Filed 2000·Granted Apr 9, 2002·58 cites·10 claims
- 1995US5268097APassivated and stabilized porous mineral oxide supports and method for the preparation and use of sameSEPRACOR INC·Filed 1992·Granted Dec 7, 1993·102 cites·38 claims
- 2094US7615572B2Pyrrole and pyrazole DAAO inhibitorsSEPRACOR INC·Filed 2008·Granted Nov 10, 2009·26 cites·8 claims
- 2194US7465729B2Methods of treatment of menopause and perimenopause using eszopicloneSEPRACOR INC·Filed 2005·Granted Dec 16, 2008·24 cites·4 claims
- 2294US7456173B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2006·Granted Nov 25, 2008·11 cites·6 claims
- 2394US7145036B2Formoterol tartrate polymorphSEPRACOR INC·Filed 2005·Granted Dec 5, 2006·20 cites·3 claims
- 2494US7105699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2005·Granted Sep 12, 2006·18 cites·10 claims
- 2594US6864257B2Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing itSEPRACOR INC·Filed 2002·Granted Mar 8, 2005·45 cites·7 claims
- 2694US6476078B2Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunctionSEPRACOR INC·Filed 2001·Granted Nov 5, 2002·43 cites·12 claims
- 2794US6369113B2Method for treating depression using optically pure (−)-bupropionSEPRACOR INC·Filed 2001·Granted Apr 9, 2002·43 cites·11 claims
- 2894US6337328B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 8, 2002·59 cites·94 claims
- 2994US6291490B1Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipineSEPRACOR INC·Filed 2000·Granted Sep 18, 2001·47 cites·9 claims
- 3094US6057344AMethods for treating hypertension, and angina using optically pure (-) amlodipineSEPRACOR INC·Filed 1994·Granted May 2, 2000·76 cites·16 claims
- 3194US5057427AMethod for resolution of stereoisomersSEPRACOR INC·Filed 1988·Granted Oct 15, 1991·64 cites·70 claims
- 3293US7589237B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2008·Granted Sep 15, 2009·14 cites·8 claims
- 3393US7579370B2Fused heterocyclesSEPRACOR INC·Filed 2007·Granted Aug 25, 2009·25 cites·15 claims
- 3493US6720453B2Formoterol tartrate polymorphSEPRACOR INC·Filed 2002·Granted Apr 13, 2004·34 cites·15 claims
- 3593US6489341B1Methods for the treatment of neuroleptic and related disorders using sertindole derivativesSEPRACOR INC·Filed 2000·Granted Dec 3, 2002·55 cites·37 claims
- 3693US6277887B1Methods for treating Parkinson's disease using optically pure (−)-bupropionSEPRACOR INC·Filed 2000·Granted Aug 21, 2001·37 cites·11 claims
- 3793US6204285B1Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolateSEPRACOR INC·Filed 1997·Granted Mar 20, 2001·158 cites·42 claims
- 3892US7776858B2Methods of treatment of chronic pain using eszopicloneSEPRACOR INC·Filed 2005·Granted Aug 17, 2010·20 cites·4 claims
- 3992US7342132B2Formoterol tartrate process and polymorphSEPRACOR INC·Filed 2006·Granted Mar 11, 2008·13 cites·2 claims
- 4092US7253156B2Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonistsSEPRACOR INC·Filed 2006·Granted Aug 7, 2007·17 cites·25 claims
- 4192US7132551B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2003·Granted Nov 7, 2006·45 cites·17 claims
- 4292US6649183B2Methods for treating apnea and apnea disorders using optically pure R(+) ondansetronSEPRACOR INC·Filed 2001·Granted Nov 18, 2003·37 cites·16 claims
- 4392US6040344AFormoterol processSEPRACOR INC·Filed 1998·Granted Mar 21, 2000·103 cites·10 claims
- 4492US5399765AEnantioselective preparation of optically pure albuterolSEPRACOR INC·Filed 1994·Granted Mar 21, 1995·41 cites·14 claims
- 4592US5258517AMethod of preparing optically pure precursors of paroxetineSEPRACOR INC·Filed 1992·Granted Nov 2, 1993·62 cites·14 claims
- 4692US4754089APhase transfer catalysisSEPRACOR INC·Filed 1986·Granted Jun 28, 1988·39 cites·40 claims
- 4791US7166725B2Benzo[d]isoxazol-3-ol DAAO inhibitorsSEPRACOR INC·Filed 2004·Granted Jan 23, 2007·47 cites·3 claims
- 4891US6992077B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2004·Granted Jan 31, 2006·43 cites·90 claims
- 4991US6866839B2Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterolSEPRACOR INC·Filed 2003·Granted Mar 15, 2005·29 cites·18 claims
- 5091US6822099B2Method of resolving amlodipine racemateSEPRACOR INC·Filed 2002·Granted Nov 23, 2004·32 cites·14 claims
Showing the top 50 of 395 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SEPRACOR INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →